Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(8.90%),David Rosen(8.90%)
Trevi Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rubric Capital Management LP(8.90%),David Rosen(8.90%)
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。